Table 3.
Comparison of general characteristics of sarcopenic patients during first and second wave: missing values were excluded from calculations.
| Sarcopenic patients |
|||||||
|---|---|---|---|---|---|---|---|
| 1-st wave n = 88 | 2-nd wave n = 25 | p-value | |||||
| Gender | M | n % | 68 | 77.3% | 12 | 48.0% | 0.0066 |
| Age | years | median IQR | 71.0 | 62–78 | 73.0 | 63–84 | 0.3597 |
| Albumin | g/dl | mean sd | 3.1 | 0.5 | 3.4 | 0.4 | 0.0033 |
| PCR | mg/dl | mean sd | 12.2 | 9.9 | 6.9 | 7.4 | 0.0071 |
| Heart diseases | yes | n % | 19 | 21.6% | 9 | 36.0% | 0.1885 |
| Hypertension | yes | n % | 50 | 56.8% | 15 | 60.0% | 0.8223 |
| Cerebrovascular diseases | yes | n % | 11 | 12.5% | 3 | 12.0% | 1.0000 |
| Diabetes | yes | n % | 18 | 20.5% | 5 | 20.0% | 1.0000 |
| Dyslipidemia | yes | n % | 29 | 33.0% | 3 | 12.0% | 0.0459 |
| COPD | yes | n % | 11 | 12.5% | 2 | 8.0% | 0.7296 |
| Asthma | yes | n % | 2 | 2.3% | 1 | 4.0% | 0.5313 |
| CKD | yes | n % | 12 | 13.6% | 2 | 8.0% | 0.7316 |
| Cancer | yes | n % | 13 | 14.8% | 7 | 28.0% | 0.1433 |
| Endocrinopathies | yes | n % | 5 | 5.7% | 3 | 12.0% | 0.3721 |
| LOS | days | mean sd | 26.8 | 18.5 | 26.6 | 20.5 | 0.8409 |
| SMA | cm2 | mean sd | 62.3 | 17.5 | 67.8 | 16.7 | 0.1899 |
| Steatosis | yes | n % | 53 | 69.7% | 12 | 48.0% | 0.0577 |
Abbreviations: M: male, n: number, SD: standard deviation, IQR: interquartile range, PCR: c-reactive protein, COPD: chronic obstructive pulmonary disease, CKD: Chronic Kidney Disease, SMA: skeletal muscle area, LOS: length of stay.
Bold characters are used to stressed significant data.